183 related articles for article (PubMed ID: 10192461)
1. Haematological parameters of parvovirus B19 infection in 13 fetuses with hydrops foetalis.
Forestier F; Tissot JD; Vial Y; Daffos F; Hohlfeld P
Br J Haematol; 1999 Mar; 104(4):925-7. PubMed ID: 10192461
[TBL] [Abstract][Full Text] [Related]
2. Thrombocytopenia in hydropic fetuses with parvovirus B19 infection: incidence, treatment and correlation with fetal B19 viral load.
de Haan TR; van den Akker ES; Porcelijn L; Oepkes D; Kroes AC; Walther FJ
BJOG; 2008 Jan; 115(1):76-81. PubMed ID: 18053103
[TBL] [Abstract][Full Text] [Related]
3. Management and outcome of pregnancies with parvovirus B19 infection over seven years in a tertiary fetal medicine unit.
Simms RA; Liebling RE; Patel RR; Denbow ML; Abdel-Fattah SA; Soothill PW; Overton TG
Fetal Diagn Ther; 2009; 25(4):373-8. PubMed ID: 19786782
[TBL] [Abstract][Full Text] [Related]
4. Nonimmune hydrops fetalis caused by intrauterine human parvovirus B19 infection: a case of spontaneous reversal in utero.
Faure JM; Giacalone PL; Deschamps F; Boulot P
Fetal Diagn Ther; 1997; 12(2):66-7. PubMed ID: 9218942
[TBL] [Abstract][Full Text] [Related]
5. Intrauterine management of fetal parvovirus B19 infection.
Schild RL; Bald R; Plath H; Eis-Hübinger AM; Enders G; Hansmann M
Ultrasound Obstet Gynecol; 1999 Mar; 13(3):161-6. PubMed ID: 10204205
[TBL] [Abstract][Full Text] [Related]
6. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases.
Enders M; Weidner A; Zoellner I; Searle K; Enders G
Prenat Diagn; 2004 Jul; 24(7):513-8. PubMed ID: 15300741
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic and therapy of a severe fetal parvovirus-B19-infection with persistence of viral DNA in the mothers blood but inconspicuous serological tests. Case report].
Stenner S; Enders G; Klee A; Eiden U; Weidner A; Gonser M
Z Geburtshilfe Neonatol; 2002; 206(3):102-6. PubMed ID: 12098826
[TBL] [Abstract][Full Text] [Related]
8. First-trimester treatment of fetal anemia secondary to parvovirus B19 infection.
Kempe A; Rösing B; Berg C; Kamil D; Heep A; Gembruch U; Geipel A
Ultrasound Obstet Gynecol; 2007 Feb; 29(2):226-8. PubMed ID: 17252527
[TBL] [Abstract][Full Text] [Related]
9. Human parvovirus B19 in pregnancy.
Brennand JE; Cameron AD
Hosp Med; 2000 Feb; 61(2):93-6. PubMed ID: 10748785
[TBL] [Abstract][Full Text] [Related]
10. Emergent fetal intracardiac transfusion for thrombocytopenia and acute hypovolemia due to cordocentesis-associated hemorrhage in parvovirus-induced hydrops.
Sarno AP; Feinstein SJ; Bell JG; Parikh R; Papazian K
Fetal Diagn Ther; 2007; 22(2):124-7. PubMed ID: 17139168
[TBL] [Abstract][Full Text] [Related]
11. B19 parvovirus-induced fetal hydrops:good outcome after intrauterine blood transfusion at 18 weeks of gestation.
Bousquet F; Segondy M; Faure JM; Deschamps F; Boulot P
Fetal Diagn Ther; 2000; 15(3):132-3. PubMed ID: 10781995
[TBL] [Abstract][Full Text] [Related]
12. Clinical features of 10 fetuses with prenatally diagnosed parvovirus b19 infection and fetal hydrops.
Kyeong KS; Won HS; Lee MY; Shim JY; Lee PR; Kim A
Fetal Pediatr Pathol; 2015 Feb; 34(1):49-56. PubMed ID: 25313841
[TBL] [Abstract][Full Text] [Related]
13. Clinical presentation and outcome of 20 fetuses with parvovirus B19 infection complicated by severe anemia and/or fetal hydrops.
Macé G; Sauvan M; Castaigne V; Moutard ML; Cortey A; Maisonneuve E; Garel C; Dhombres F; Boujenah J; Mailloux A; Carbonne B
Prenat Diagn; 2014 Nov; 34(11):1023-30. PubMed ID: 24851784
[TBL] [Abstract][Full Text] [Related]
14. Parvovirus B19 in Pregnancy.
Boissiere J; Watkins V; Kuller JA; Dotters-Katz SK
Obstet Gynecol Surv; 2024 May; 79(5):281-289. PubMed ID: 38764205
[TBL] [Abstract][Full Text] [Related]
15. Postnatal IVIG treatment for persistent anaemia in neonate due to congenital parvovirus infection.
Janssen O; Lin J
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33431449
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection.
Nagel HT; de Haan TR; Vandenbussche FP; Oepkes D; Walther FJ
Obstet Gynecol; 2007 Jan; 109(1):42-7. PubMed ID: 17197586
[TBL] [Abstract][Full Text] [Related]
17. Serologic study of human parvovirus B19 infection in pregnancy in Japan.
Yaegashi N; Niinuma T; Chisaka H; Uehara S; Okamura K; Shinkawa O; Tsunoda A; Moffatt S; Sugamura K; Yajima A
J Infect; 1999 Jan; 38(1):30-5. PubMed ID: 10090504
[TBL] [Abstract][Full Text] [Related]
18. One stillborn and one severely hydropic twin due to parvovirus B19 infection; successful outcome of the surviving twin.
Wolff K; Broliden K; Marsk A; Tolfvenstam T; Papadogiannakis N; Westgren M
Acta Obstet Gynecol Scand; 1999 Oct; 78(9):828-30. PubMed ID: 10535353
[No Abstract] [Full Text] [Related]
19. Late onset of hydrops fetalis following intrauterine parvovirus B19 infection.
Mielke G; Enders G
Fetal Diagn Ther; 1997; 12(1):40-2. PubMed ID: 9101221
[TBL] [Abstract][Full Text] [Related]
20. In utero treatment of severe fetal anaemia due to parvovirus B19 in one fetus in a twin pregnancy--a case report and literature review.
Bekhit MT; Greenwood PA; Warren R; Aarons E; Jauniaux E
Fetal Diagn Ther; 2009; 25(1):153-7. PubMed ID: 19293585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
